Haematologica (Jun 2023)
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia
- Tracy Murphy,
- Jinfeng Zou,
- Andrea Arruda,
- Ting Ting Wang,
- Zhen Zhao,
- Yangqiao Zheng,
- Vikas Gupta,
- Dawn Maze,
- Caroline McNamara,
- Mark D. Minden,
- Aaron Schimmer,
- Hassan Sibai,
- Karen Yee,
- Jose-Mario Capo-Chichi,
- Tracy Stockley,
- Andre Schuh,
- Scott V. Bratman,
- Steven M. Chan
Affiliations
- Tracy Murphy
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Jinfeng Zou
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Andrea Arruda
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Ting Ting Wang
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Zhen Zhao
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Yangqiao Zheng
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Vikas Gupta
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Dawn Maze
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Caroline McNamara
- Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia
- Mark D. Minden
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Aaron Schimmer
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Hassan Sibai
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Karen Yee
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Jose-Mario Capo-Chichi
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON
- Tracy Stockley
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON
- Andre Schuh
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Scott V. Bratman
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- Steven M. Chan
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario
- DOI
- https://doi.org/10.3324/haematol.2023.283510
- Journal volume & issue
-
Vol. 109,
no. 2
Abstract
No abstracts available.